全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Polyunsaturated Fatty Acids and Modulation of Cholesterol Homeostasis in THP-1 Macrophage-Derived Foam Cells

DOI: 10.3390/ijms11114660

Keywords: THP-1, conjugated linoleic acid, α-linlenic acid, eicosapentaenoic acid, liver X receptor α, ATP-binding cassette A1

Full-Text   Cite this paper   Add to My Lib

Abstract:

Transformation of macrophages to foam cells is determined by the rates of cholesterol uptake and efflux. This study uses a real time RT-PCR technique to investigate the role of conjugated linoleic acid (CLA), α-linolenic acid (ALA) and eicosapentaenoic acid (EPA) in the regulation of the ATP-binding cassette A1 (ABCA1) and liver X receptor α (LXR) genes, which are involved in cholesterol homeostasis. Accordingly, these fatty acids significantly reduced the total, free and esterified cholesterols within the foam cells. While the expression of the ABCA1 and LXRα genes was increased in the presence of the pharmacological LXRα ligand, T0901317, their mRNA expression was not significantly affected by CLA, ALA and EPA. These results suggest that although polyunsaturated fatty acids have an effect on cholesterol homeostasis, they cannot change the expression of the ABCA1 and LXRα genes. Alternatively, several other genes and proteins may be involved.

References

[1]  Ross, R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med 1999, 340, 115–126.
[2]  von Eckardstein, A; Nofer, JR; Assmann, G. High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport. Arterioscler. Thromb. Vasc. Biol 2001, 21, 13–27.
[3]  Bodzioch, M; Orso, E; Klucken, J; Langmann, T; Bottcher, A; Diederich, W; Drobnik, W; Barlage, S; Buchler, C; Porsch-Ozcurumez, M; et al. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet 1999, 22, 347–351.
[4]  Brooks-Wilson, A; Marcil, M; Clee, SM; Zhang, LH; Roomp, K; van Dam, M; Yu, L; Brewer, C; Collins, JA; Molhuizen, HO; et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet 1999, 22, 336–345.
[5]  Rust, S; Rosier, M; Funke, H; Real, J; Amoura, Z; Piette, JC; Deleuze, JF; Brewer, HB; Duverger, N; Denefle, P; et al. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet 1999, 22, 352–355.
[6]  Costet, P; Luo, Y; Wang, N; Tall, AR. Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J. Biol. Chem 2000, 275, 28240–28245.
[7]  Repa, JJ; Mangelsdorf, DJ. The role of orphan nuclear receptors in the regulation of cholesterol homeostasis. Annu. Rev. Cell Dev. Biol 2000, 16, 459–481.
[8]  Schwartz, K; Lawn, RM; Wade, DP. ABC1 gene expression and ApoA-I-mediated cholesterol efflux are regulated by LXR. Biochem. Biophys. Res. Commun 2000, 274, 794–802.
[9]  Venkateswaran, A; Laffitte, BA; Joseph, SB; Mak, PA; Wilpitz, DC; Edwards, PA; Tontonoz, P. Control of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alpha. Proc. Natl. Acad. Sci. USA 2000, 97, 12097–12102.
[10]  Uehara, Y; Engel, T; Li, Z; Goepfert, C; Rust, S; Zhou, X; Langer, C; Schachtrup, C; Wiekowski, J; Lorkowski, S; Assmann, G; von Eckardstein, A. Polyunsaturated fatty acids and acetoacetate downregulate the expression of the ATP-binding cassette transporter A1. Diabetes 2002, 51, 2922–2928.
[11]  Suresh, Y; Das, UN. Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus. Effect of omega-3 fatty acids. Nutrition 2003, 19, 213–228.
[12]  Hwang, D. Fatty acids and immune responses--a new perspective in searching for clues to mechanism. Annu. Rev. Nutr 2000, 20, 431–456.
[13]  Ntambi, JM; Choi, Y; Park, Y; Peters, JM; Pariza, MW. Effects of conjugated linoleic acid (CLA) on immune responses, body composition and stearoyl-CoA desaturase. Can. J. Appl. Physiol 2002, 27, 617–628.
[14]  Harris, WS; Lu, G; Rambjor, GS; Walen, AI; Ontko, JA; Cheng, Q; Windsor, SL. Influence of n-3 fatty acid supplementation on the endogenous activities of plasma lipases. Am. J. Clin. Nutr 1997, 66, 254–260.
[15]  Rambjor, GS; Walen, AI; Windsor, SL; Harris, WS. Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans. Lipids 1996, 31, S45–S49.
[16]  Schwartz, J. Role of polyunsaturated fatty acids in lung disease. Am. J. Clin. Nutr 2000, 71, 393S–396S.
[17]  Siscovick, DS; Raghunathan, T; King, I; Weinmann, S; Bovbjerg, VE; Kushi, L; Cobb, LA; Copass, MK; Psaty, BM; Lemaitre, R; Retzlaff, B; Knopp, RH. Dietary intake of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. Am. J. Clin. Nutr 2000, 71, 208S–212S.
[18]  Skerrett, PJ; Hennekens, CH. Consumption of fish and fish oils and decreased risk of stroke. Prev. Cardiol 2003, 6, 38–41.
[19]  von Schacky, C. n-3 fatty acids and the prevention of coronary atherosclerosis. Am. J. Clin. Nutr 2000, 71, 224S–227S.
[20]  Toomey, S; Roche, H; Fitzgerald, D; Belton, O. Regression of pre-established atherosclerosis in the apoE-/- mouse by conjugated linoleic acid. Biochem. Soc. Trans 2003, 31, 1075–1079.
[21]  Hu, YW; Ma, X; Li, XX; Liu, XH; Xiao, J; Mo, ZC; Xiang, J; Liao, DF; Tang, CK. Eicosapentaenoic acid reduces ABCA1 serine phosphorylation and impairs ABCA1-dependent cholesterol efflux through cyclic AMP/protein kinase A signaling pathway in THP-1 macrophage-derived foam cells. Atherosclerosis 2009, 204, e35–e43.
[22]  Lu, TT; Repa, JJ; Mangelsdorf, DJ. Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism. J. Biol. Chem 2001, 276, 37735–37738.
[23]  Joseph, SB; Laffitte, BA; Patel, PH; Watson, MA; Matsukuma, KE; Walczak, R; Collins, JL; Osborne, TF; Tontonoz, P. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J. Biol. Chem 2002, 277, 11019–11025.
[24]  Ou, J; Tu, H; Shan, B; Luk, A; DeBose-Boyd, RA; Bashmakov, Y; Goldstein, JL; Brown, MS. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc. Natl. Acad. Sci. USA 2001, 98, 6027–6032.
[25]  Schultz, JR. Role of LXRs in control of lipogenesis. Genes Dev 2000, 14, 2831–2838.
[26]  Laffitte, BA; Repa, JJ; Joseph, SB; Wilpitz, DC; Kast, HR; Mangelsdorf, DJ; Tontonoz, P. LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc. Natl. Acad. Sci. USA 2001, 98, 507–512.
[27]  Venkateswaran, A. Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols. J. Biol. Chem 2000, 275, 14700–14707.
[28]  Joseph, SB; McKilligin, E; Pei, L; Watson, MA; Collins, AR; Laffitte, BA; Chen, M; Noh, G; Goodman, J; Hagger, GN; et al. Synthetic LXR ligand inhibits the development of atherosclerosis in mice. Proc. Natl. Acad. Sci. USA 2002, 99, 7604–7609.
[29]  Tobin, KA; Steineger, HH; Alberti, S; Spydevold, O; Auwerx, J; Gustafsson, JA; Nebb, HI. Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-alpha. Mol. Endocrinol 2000, 14, 741–752.
[30]  Pawar, A; Botolin, D; Mangelsdorf, DJ; Jump, DB. The role of liver X receptor-alpha in the fatty acid regulation of hepatic gene expression. J. Biol. Chem 2003, 278, 40736–40743.
[31]  Rustan, AC; Nossen, JO; Osmundsen, H; Drevon, CA. Eicosapentaenoic acid inhibits cholesterol esterification in cultured parenchymal cells and isolated microsomes from rat liver. J. Biol. Chem 1988, 263, 8126–8132.
[32]  Pal, S; Davis, PJ. Effects of different types of polyunsaturated fatty acids on cholesterol esterification in human fibroblasts. Biochem. Int 1991, 25, 281–288.
[33]  Uehara, Y; Miura, S; von Eckardstein, A; Abe, S; Fujii, A; Matsuo, Y; Rust, S; Lorkowski, S; Assmann, G; Yamada, T; Saku, K. Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element. Atherosclerosis 2007, 191, 11–21.
[34]  Desvergne, B; Wahli, W. Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocr. Rev 1999, 20, 649–688.
[35]  Chinetti-Gbaguidi, G; Rigamonti, E; Helin, L; Mutka, AL; Lepore, M; Fruchart, JC; Clavey, V; Ikonen, E; Lestavel, S; Staels, B. Peroxisome proliferator-activated receptor alpha controls cellular cholesterol trafficking in macrophages. J. Lipid Res 2005, 46, 2717–2725.
[36]  Ringseis, R; Wen, G; Saal, D; Eder, K. Conjugated linoleic acid isomers reduce cholesterol accumulation in acetylated LDL-induced mouse RAW264.7 macrophage-derived foam cells. Lipids 2008, 43, 913–923.
[37]  Moya-Camarena, SY; Vanden Heuvel, JP; Blanchard, SG; Leesnitzer, LA; Belury, MA. Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha. J. Lipid Res 1999, 40, 142614–142633.
[38]  Hirakata, M; Tozawa, R; Imura, Y; Sugiyama, Y. Comparison of the effects of pioglitazone and rosiglitazone on macrophage foam cell formation. Biochem. Biophys. Res. Commun 2004, 323, 782–788.
[39]  Davis, PJ. n-3 and n-6 polyunsaturated fatty acids have different effects on acyl-CoA: Cholesterol acyltransferase in J774 macrophages. Biochem. Cell Biol 1992, 70, 1313–1318.
[40]  Pietsch, A; Weber, C; Goretzki, M; Lornz, RL. N-3 but not N-6 fatty acids reduce the expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells. Cell Biochem. Funct 1995, 13, 211–216.
[41]  Chinetti, G; Gbaguidi, FG; Griglio, S; Mallat, A; Antonucci, M; Poulain, P; Chapman, J; Fruchart, J-C; Tedgui, A; Najib-Fruchart, J; Staels, B. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation 2000, 101, 2411–2417.
[42]  Weldon, S; Mitchell, S; Kelleher, D; Gibney, MJ; Roche, HM. Conjugated linoleic acid and atherosclerosis: No effect on molecular markers of cholesterol homeostasis in THP-1 macrophages. Atherosclerosis 2004, 174, 261–273.
[43]  Havel, RJ; Eder, HA; Bragdon, JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest 1955, 34, 1345–1353.
[44]  Fraenkel-Conrat, H. Methods Forinvestigatingthe Essentialgroups for Enzymeactivity. Method in Enzymology; s.p. colowick & n. o. kaplan: New York, NY, USA, 1957. Volume 4; pp. 247–269.
[45]  Via, DP; Plant, AL; Craig, IF; Gotto, AM; Smith, LC. Metabolism of normal and modified low-density lipoproteins by macrophage cell lines of murine and human origin. Biochim. Biophys. Acta 1985, 833, 417–428.
[46]  Scudiero, DA; Shoemaker, RH; Paull, KD; Monks, A; Tierney, S; Nofziger, TH; Currens, MJ; Seniff, D; Boyd, MR. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 1988, 48, 4827–4833.
[47]  Iida, KT; Kawakami, Y; Suzuki, H; Sone, H; Shimano, H; Toyoshima, H; Okuda, Y; Yamada, N. PPAR gamma ligands, troglitazone and pioglitazone, up-regulate expression of HMG-CoA synthase and HMG-CoA reductase gene in THP-1 macrophages. FEBS Lett 2002, 520, 177–181.
[48]  Kehrer, JP; Biswal, SS; La, E; Thuillier, P; Datta, K; Fischer, SM; Vanden Heuvel, JP. Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886. Biochem. J 2001, 356, 899–906.
[49]  Bradford, MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem 1976, 72, 248–254.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133